BlackRock Amends CVS Health Stake, Signals Portfolio Shift
Ticker: CVS · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 64803
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, portfolio-change
TL;DR
**BlackRock updated its CVS Health ownership, signaling a potential shift in its investment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in their ownership of CVS Health Corp. common stock as of December 31, 2023. This filing, Amendment No. 11, updates their previous disclosures regarding their stake in the retail-drug store giant. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal shifts in their confidence or investment strategy regarding CVS Health, potentially influencing other investors.
Why It Matters
Changes in major institutional holdings like BlackRock's can influence market sentiment and potentially impact CVS Health's stock price, as large investors often move significant capital.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and doesn't inherently signal high risk, but rather a change in ownership percentage.
Analyst Insight
An investor should monitor subsequent filings from BlackRock or other major institutions to understand the magnitude and direction of any changes in their CVS Health holdings, as this filing only indicates an amendment, not the specific change in percentage.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- CVS HEALTH Corp (company) — the subject company whose shares are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 11 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 11'.
Who is the subject company of this filing?
The subject company is CVS HEALTH Corp, identified by 'COMPANY CONFORMED NAME: CVS HEALTH Corp' and 'Name of Issuer: CVS HEALTH CORPORATION'.
Who filed this SC 13G/A?
This SC 13G/A was filed by BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under 'Date of Event Which Requires Filing of this Statement'.
What is the CUSIP number for the securities reported in this filing?
The CUSIP number for the Common Stock of CVS Health Corporation is 126650100, as listed under 'CUSIP Number'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding CVS HEALTH Corp (CVS).